Allianz Asset Management Gmb H Neurocrine Biosciences Inc Transaction History

Allianz Asset Management Gmb H

$74.9 Billion
Q2 2025

A detailed history of Allianz Asset Management Gmb H transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 16,552 shares of NBIX stock, worth $2.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,552

Previous 25,038 33.89%

Holding current value

$2.28 Million

Previous $2.77 Million 24.88%

% of portfolio

0.0%

Previous 0.0%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	SELL	$87.54 - $128.18 $742,864 - $1.09 Million	-8,486 Reduced 33.89%	16,552 $2.08 Million
Q1 2025 May 05, 2025	SELL	$107.22 - $153.29 $362,403 - $518,120	-3,380 Reduced 11.89%	25,038 $2.77 Million
Q4 2024 Feb 03, 2025	BUY	$111.62 - $139.44 $7,701 - $9,621	69 Added 0.24%	28,418 $3.88 Million
Q3 2024 Nov 12, 2024	BUY	$114.58 - $153.15 $764,936 - $1.02 Million	6,676 Added 30.8%	28,349 $3.26 Million
Q2 2024 Aug 13, 2024	SELL	$130.86 - $143.19 $758,333 - $829,786	-5,795 Reduced 21.1%	21,673 $2.98 Million
Q1 2024 May 13, 2024	SELL	$130.4 - $143.74 $279,056 - $307,603	-2,140 Reduced 7.23%	27,468 $3.79 Million
Q4 2023 Feb 12, 2024	SELL	$106.07 - $132.76 $5.57 Million - $6.97 Million	-52,518 Reduced 63.95%	29,608 $3.9 Million
Q3 2023 Nov 13, 2023	SELL	$94.02 - $117.1 $164,158 - $204,456	-1,746 Reduced 2.08%	82,126 $9.24 Million
Q2 2023 Aug 11, 2023	SELL	$89.53 - $104.87 $14.1 Million - $16.5 Million	-157,121 Reduced 65.2%	83,872 $7.91 Million
Q1 2023 May 11, 2023	SELL	$94.11 - $123.02 $935,076 - $1.22 Million	-9,936 Reduced 3.96%	240,993 $24.4 Million
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $7.86 Million - $9.35 Million	73,619 Added 41.52%	250,929 $30 Million
Q3 2022 Nov 08, 2022	SELL	$92.03 - $107.81 $6.29 Million - $7.37 Million	-68,354 Reduced 27.82%	177,310 $18.8 Million
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $1.54 Million - $2.04 Million	-20,358 Reduced 7.65%	245,664 $23.9 Million
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $4.87 Million - $6.38 Million	67,248 Added 33.83%	266,022 $24.9 Million
Q4 2021 Feb 11, 2022	SELL	$79.65 - $106.22 $1.8 Million - $2.41 Million	-22,653 Reduced 10.23%	198,774 $16.9 Million
Q3 2021 Nov 10, 2021	BUY	$86.18 - $99.03 $5.07 Million - $5.83 Million	58,850 Added 36.2%	221,427 $21.2 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $7.52 Million - $8.6 Million	84,096 Added 107.15%	162,577 $15.8 Million
Q1 2021 May 13, 2021	BUY	$87.57 - $119.4 $79,338 - $108,176	906 Added 1.17%	78,481 $7.63 Million
Q4 2020 Feb 16, 2021	BUY	$86.91 - $108.33 $2.33 Million - $2.91 Million	26,844 Added 52.91%	77,575 $7.44 Million
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $966,023 - $1.36 Million	10,046 Added 24.69%	50,731 $4.88 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $269,905 - $413,501	-3,172 Reduced 7.23%	40,685 $4.96 Million
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $919,271 - $1.39 Million	-12,239 Reduced 21.82%	43,857 $3.8 Million
Q4 2019 Feb 13, 2020	SELL	$86.8 - $118.57 $4.96 Million - $6.77 Million	-57,135 Reduced 50.46%	56,096 $6.03 Million
Q3 2019 Nov 13, 2019	SELL	$83.82 - $101.5 $3.74 Million - $4.53 Million	-44,625 Reduced 28.27%	113,231 $10.2 Million
Q2 2019 Aug 08, 2019	SELL	$72.24 - $91.27 $487,547 - $615,981	-6,749 Reduced 4.1%	157,856 $13.3 Million
Q1 2019 May 13, 2019	SELL	$69.31 - $91.53 $8.44 Million - $11.1 Million	-121,765 Reduced 42.52%	164,605 $14.5 Million
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $5.57 Million - $10.1 Million	-81,536 Reduced 22.16%	286,370 $20.4 Million
Q3 2018 Nov 13, 2018	SELL	$98.88 - $125.85 $164,437 - $209,288	-1,663 Reduced 0.45%	367,906 $45.2 Million
Q2 2018 Aug 13, 2018	SELL	$75.3 - $105.99 $2 Million - $2.81 Million	-26,531 Reduced 6.7%	369,569 $36.3 Million
Q1 2018 May 14, 2018	BUY	$75.88 - $92.43 $3.47 Million - $4.23 Million	45,775 Added 13.07%	396,100 $32.8 Million
Q4 2017 Feb 13, 2018	BUY	$58.53 - $77.59 $18.2 Million - $24.1 Million	310,214 Added 773.39%	350,325 $27.2 Million
Q3 2017 Nov 13, 2017	BUY	$47.97 - $61.28 $3,597 - $4,596	75 Added 0.19%	40,111 $2.46 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-184,833 Reduced 82.2%	40,036 $1.85 Million
Q4 2016 Apr 17, 2019	SELL	N/A	-3,876 Reduced 1.69%	224,869 $8.7 Million
Q3 2016 Apr 17, 2019	BUY	N/A	228,745	228,745 $11.5 Million

Others Institutions Holding NBIX

# of Institutions

660

Shares Held

102M

Call Options Held

290K

Put Options Held

214K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Neurocrine Biosciences Inc Transaction History